ArticleTobacco induced diseases2026
Smoking shapes the relationship between metabolic biomarkers and femoral-neck bone mineral density: A stratified analysis by smoking status.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBone mineral density (BMD) is a crucial indicator of bone strength and osteoporosis risk. Smoking is known to negatively impact bone health and related bone metabolism biomarkers. However, if and how smoking status influences the relationship between bone metabolism biomarkers and BMD, particularly measured at the femoral neck, remains poorly understood. The objective of this study was to examine the relationship between bone metabolism biomarkers and BMD stratified by smoking status.
methodsData from 4464 healthy individuals were collected from the Qatar Biobank. The sample was divided into smokers, non-smokers, and ex-smokers, and logistic regression was used to examine relationships between biochemical markers and femoral-neck BMD in the different subgroups.
resultsSex, age, and body mass index consistently influenced BMD across all smoking strata. Males and older individuals were at higher risk of low BMD, while higher BMI was protective. Creatinine levels were positively associated with BMD in all groups. Alkaline phosphate (ALP) was significantly associated with BMD in non-smokers and ex-smokers but not in smokers, while cholesterol levels were negatively associated with BMD in non-smokers and smokers but not in ex-smokers.
conclusionsSmoking status impacts the relationship between metabolism-related biomarkers and BMD, highlighting the need for smoking status-specific bone health guidelines. These findings emphasize the importance of including smoking history in clinical bone health assessments and suggest that personalized approaches may be necessary to mitigate the risk of bone deterioration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.